Anthony Chau, MD
Vascular Surgery · Orange, CANPI 1699055988
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Inari Medical, Inc. at 55.2% of the total. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $177.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$31K
- Stryker$10K
- Medtronic$6K
- W. L. Gore & Associates, Inc.$4K
- Cook Medical LLC$2K
- Silk Road Medical, Inc.$2K
- plus $3K from 26 others
Across 37 payments — averaging $4566.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$64K
- Humacyte Global, Inc.$44K
- Medtronic$39K
- W. L. Gore & Associates, Inc.$19K
- Stryker$4K
What the payments were for
- Consulting fees$28,95051%
- Speaking & faculty fees$12,67522%
- Travel & lodging$1,7233%
- Food & beverage$13,67024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 32 | $31,449 |
| Stryker(2 entities) | 9 | $9,663 |
| Medtronic(2 entities) | 69 | $5,541 |
| W. L. Gore & Associates, Inc. | 70 | $3,867 |
| Cook Medical LLC | 49 | $1,942 |
| Silk Road Medical, Inc. | 35 | $1,536 |
| Bolton Medical Inc | 9 | $523 |
| Shockwave Medical, Inc | 5 | $450 |
| Philips North America LLC | 4 | $219 |
| Johnson & Johnson | 2 | $193 |
| Bard Peripheral Vascular, Inc. | 2 | $190 |
| Integra Lifesciences Corporation | 5 | $154 |
| Boston Scientific | 4 | $139 |
| Davol Inc. | 2 | $126 |
| Microtransponder, Inc. | 1 | $125 |
| Endologix LLC | 2 | $107 |
| Urgo Medical North America, LLC | 3 | $76 |
| Sirtex Medical Inc | 1 | $75 |
| Inspiremd Ltd | 2 | $73 |
| Terumo Medical Corporation | 2 | $70 |
| Acell, Inc. | 1 | $67 |
| Vasorum USA Inc. | 1 | $63 |
| Getinge USA Sales, LLC | 2 | $62 |
| Baxter Healthcare | 1 | $58 |
| Cvrx, Inc. | 2 | $54 |
| Lifenet Health | 1 | $47 |
| My01 Inc. | 1 | $45 |
| Merit Medical Systems Inc | 1 | $38 |
| Solventum Corporation | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$40,411
- CT THROMBECTOMY SYSTEM KIT$40,411
- GORE TAG Thoracic Endoprosthesis$802
- ENDURANT IIS$716
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$454
- ENROUTE Transcarotid Neuroprotection System$437
- Valiant Captivia$403
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$298
- ENROUTE Transcarotid Stent$277
- TREO ABDOMINAL STENT-GRAFT SYSTEM$163
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$159
- Lutonix Drug Coated Balloon$152
- GORE TAG Thoracic Branch Endoprosthesis$146
- VISTASEAL$144
- ETHICON$144
- Zenith Spiral-Z$125
- ENROUTE .014 Guidewire$118
- ENHANCE Transcarotid Peripheral Access Kit$118
- Cook$102
How this compares
$57,018 in reported general payments places this provider in the 90th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $204 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Orange
- Roy FujitaniOrange$57K
- Samuel ChenOrange$42K
- Nii-Kabu KabuteyOrange$31K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.